Jazz Pharmaceuticals Plc

( )
JAZZ PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc 4.13%6.051.6%$147.89m
VRXValeant Pharmaceuticals International, Inc. 14.92%18.0214.1%$106.03m
PRGOPerrigo Co. Plc 3.15%50.396.8%$87.99m
JAZZJazz Pharmaceuticals Plc 1.13%109.692.3%$81.11m
CTLTCatalent, Inc. 2.58%56.522.2%$76.89m
ICLRICON plc 1.46%153.414.2%$74.57m
HZNPHorizon Therapeutics Plc -0.61%31.036.5%$72.36m
AXSMAxsome Therapeutics, Inc. -3.52%56.151.9%$69.95m
UTHRUnited Therapeutics Corp. -0.75%95.8714.3%$69.32m
GWPHGW Pharmaceuticals Plc -1.35%96.336.2%$56.81m
ICPTIntercept Pharmaceuticals, Inc. 3.30%69.2616.8%$45.74m
SAGESAGE Therapeutics, Inc. -3.27%29.038.6%$42.09m
PBHPrestige Consumer Healthcare, Inc. 0.42%40.444.0%$35.04m
PCRXPacira Biosciences, Inc. 6.89%35.6910.4%$32.51m
MNKMallinckrodt Plc 27.53%3.6620.9%$32.27m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.